𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗶𝗱𝗲𝗮𝘀, 𝗻𝗲𝘄 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗼𝗻𝘀, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗹𝗮𝘁𝗲𝘀𝘁 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗶𝗻 #oncology 𝗥&𝗗 𝗮𝗻𝗱 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁—#BioEurope 𝗵𝗮𝗱 𝗶𝘁 𝗮𝗹𝗹!🌟 It is truly an exciting time for #biotech and #pharma, with constant waves of innovative platforms and pioneering technologies emerging in oncology and across the therapeutic landscape. It was inspiring to dive into new types of modalities and witness the cross-pollination of these advancements. 🚀 A huge thank you to everyone who took the time to meet us and share ideas. Let’s keep the conversation going - together, we can drive the future of #cancer treatment forward! 🤝
Epigene Labs’ Post
More Relevant Posts
-
As #oncology continues to drive growth in the global pharma market, there is increasing interest in new combinations and drug modalities. Explore the trends and innovation shaping the future of #cancer care in this new blog. https://bit.ly/3UQngTJ #IQVIAMIDAS #AnalyticsLink
-
Unlock deals, alliances, and BD&L contacts to propel your strategic growth in oncology. Dive into insights now! Book your 30 min demo here: https://lnkd.in/d4_52kjn #cancer #oncology #cancerresearch #drugdiscovery #drugdevelopment #1stoncology #biotech #pharma #immunooncology #clinicaltrials #academic #businessdevelopment #searchandevaluation #commercialopportunities
-
Please reach out if ONCrg tumor experts can help free up your time or schedule a meet if you would like to learn more #ONCRG #ASCO24!
ASCO 2024 is approaching fast. Are your clinical/scientific competitive intelligence needs fully covered?💡If there are any gaps, ONCrg can provide immediate help in up to 30 cancer drug markets. For over 10 years, large and small biopharma companies have relied on ONCrg Conference coverage - because we save them time, money and provide unparalleled CI. Our dedicated tumor experts identify impactful data and provide clients with the context to make informed decisions.📊📈 Reach out to Megan Boone, Brittany Daggett, or Erica Wescott, MSc. to request your personalized ONCrg ASCO planner today! #ASCO24 #oncology #conferenceinsights #competitivestrategy
-
-
Explore the latest oncology innovations: New analysis of 5,000+ Commercial Opportunity Projects from over 100 leading universities worldwide. Book your 30 min demo here: https://lnkd.in/dii3FECB #cancer #oncology #cancerresearch #drugdiscovery #drugdevelopment #1stoncology #biotech #pharma #immunooncology #clinicaltrials #academic #businessdevelopment #searchandevaluation #commercialopportunities
-
-
As #ESMO2024 draws to a close, it's clear that even as #oncology enters the second half of the second decade of being the world's most valuable therapy area, the innovative pipeline for cancer therapies remains exceptionally strong, with exciting new MoAs emerging in bispecifics, anti-body-drug conjugates, and radioligands. However, pipeline promise needs to translate to commercial reality for success. Find out more in our exciting webinar on September 26th, where we'll be talking the oncology pipe and oncology #LaunchExcellence - register now!
Take a deep dive into the evolving #oncology innovation area. Expect insights into how to navigate this fast-paced environment and how to achieve oncology launch excellence, and learn from real life case studies. Register today: https://bit.ly/3Zh56x7
-
-
What modalities are driving growth in the #oncology market? How can developers of oncology compete in this busy space? What factors drive launch success? Join #IQVIA's webinar on 26 September 2-3 pm CSET to hear our consulting experts share their analysis and insights.
Take a deep dive into the evolving #oncology innovation area. Expect insights into how to navigate this fast-paced environment and how to achieve oncology launch excellence, and learn from real life case studies. Register today: https://bit.ly/3Zh56x7
-
-
How can well-designed emulated RCTs built from high-quality #RWE replicate findings from pivotal RCTs in #oncology? When are they inappropriate due to data quality, bias, or confounding? Aetion's #CAREInitiative seeks to answer these questions, setting new precedents for using RWE to complement RCTs in #regulatory decision-making. Meet with us at ASCO to learn how the CARE Initiative is shaping oncology research. 👉 Schedule a meeting by mentioning ASCO here: https://hubs.li/Q02yPK8c0 #ASCO24
-
-
Katrina Pedersen, MD, shared her excitement about cancer clinical trials in myTRIAList's AZUR-1 study overview video. To keep up to date on the latest trial-overview videos in CancerCare's myTRIAList Trial Finder, subscribe to our YouTube channel here: https://buff.ly/4bDeAWs #oncology #clinicaltrials #pharma #md #biotech #cancerresearch
AZUR-1 Investigator Teaser
-
🕰️Why wait hours for results when we can deliver within minutes? Our biobank delivers unparalleled speed with an ischemic time under 10 minutes, which sets new benchmarks in your cancer research. With our proprietary global clinical network, we ensure top tier biospecimen quality and excellence in delivering results for your drug discovery program. Learn more https://bit.ly/3Uj4Olb #biobanking #oncology
-
Fascinating webinar on how three key new modalities will impact oncology care and what that means for industry.
Take a deep dive into the evolving #oncology innovation area. Expect insights into how to navigate this fast-paced environment and how to achieve oncology launch excellence, and learn from real life case studies. Register today: https://bit.ly/3Zh56x7
-
Co-founder & CEO @ Epigene Labs
1moKevin Cho and I had a such a great time catching up with innovators in biotech and pharma, and discovering Stockholm.